GSK to pay $1 bln for exclusive license to J&J's hepatitis B therapy - Reuters

Reuters | Oct. 31, 2023, 1:59 p.m. | Original
GSK to pay $1 bln for exclusive license to J&J's hepatitis B therapy Reuters
Valeo announces sale of Russian thermal systems business to NPK ... - Reuters.com Orange juice prices hit all-time high amid bleak production outlook - Reuters